Related Experiment Video
Updated: Jun 22, 2026

A Metadata Extraction Approach for Clinical Case Reports to Enable Advanced Understanding of Biomedical Concepts
Published on: September 20, 2018
[Juvenile dermatomyositis associated with anasarca - a clinical case]
Ana Filipa Mourão1, Teresa Laura Pinto, Sandra Falcão
1Serviço de Reumatologia, Centro Hospitalar de Lisboa Ocidental, EPE, Hospital Egas Moniz, 1349-019 Lisboa. filipamourao@yahoo.com
Juvenile dermatomyositis (JDM) is a rare autoimmune disease. This case highlights generalized edema as a rare, severe JDM manifestation linked to poor outcomes.
Area of Science:
- Rheumatology
- Pediatrics
- Genetics
Background:
- Juvenile dermatomyositis (JDM) is a rare systemic autoimmune disease of unknown cause.
- It presents with muscle weakness, skin rashes, elevated muscle enzymes, and specific diagnostic findings.
- Severe JDM can involve lungs, gastrointestinal tract, calcinosis, and generalized edema.
Observation:
- A 14-year-old female presented with JDM and generalized edema.
- Generalized edema is a rare manifestation in JDM cases.
- This presentation is often associated with a poor prognosis.
Findings:
- The case involved a rare manifestation of JDM (generalized edema).
- The patient's presentation suggests a link between severe JDM and generalized edema.
- Tumour Necrosis Factor (TNF) genotype -308 AA may be associated with JDM chronicity.
Implications:
- Recognizing generalized edema is crucial for identifying severe JDM.
- Early identification of severe JDM manifestations can guide treatment strategies.
- Further research into genetic factors like TNF may improve JDM management.
Related Concept Videos
Nephrotic Syndrome II : Assessment and Medical Management
Nephrotic Syndrome I : Introduction
Skin Diseases and Disorders
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
Asthma III: Clinical Manifestations
Nephrotic Syndrome III : Nursing Management
Inflammatory Bowel Disease IV: Clinical Manifestations